| 前收市價 | 4.9500 |
| 開市 | 4.9300 |
| 買盤 | 4.8800 x 100 |
| 賣出價 | 4.9800 x 100 |
| 今日波幅 | 4.8900 - 5.0000 |
| 52 週波幅 | 1.8650 - 40.5800 |
| 成交量 | |
| 平均成交量 | 1,369,828 |
| 市值 | 348.267M |
| Beta 值 (5 年，每月) | 0.47 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -3.2400 |
| 業績公佈日 | 2024年3月25日 - 2024年3月29日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 10.70 |
Insider MonkeyVentyx Biosciences, Inc. (NASDAQ:VTYX) Q1 2024 Earnings Call Transcript
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Q1 2024 Earnings Call Transcript May 11, 2024 Ventyx Biosciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and gentlemen and welcome to the Ventyx Biosciences First Quarter 2024 Earnings Conference Call. […]
ZacksWhat Makes Ventyx Biosciences (VTYX) a New Buy Stock
Ventyx Biosciences (VTYX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Insider Monkey12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
In this article we present the list of 12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds. Click to skip past our discussion of the biotech space and straight to the 5 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds. Alkermes plc (NASDAQ:ALKS), Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) and ImmunoGen, Inc. […]
